Roberts J A, Challenor V F, Waller D G
Clinical Pharmacology, Southampton General Hospital, UK.
Eur J Clin Pharmacol. 1992;42(2):147-50. doi: 10.1007/BF00278474.
We have demonstrated in a group of 10 patients with CAO that treatment with xamoterol (200 mg b.i.d. for 7 days) did not alter lung function or respiratory symptoms. These results suggest that xamoterol can be used to treat mild heart failure in patients with CAO.
我们在一组10例慢性气道阻塞(CAO)患者中证明,使用昔莫罗尔治疗(200毫克,每日两次,共7天)并未改变肺功能或呼吸道症状。这些结果表明,昔莫罗尔可用于治疗CAO患者的轻度心力衰竭。